Concepedia

Author

Stephen H. Docter

Skin Research Center

Also Known As

S. DOCTER, S. H. Docter, Stephen H. Docter

6

Publications

152

Citations

5

H-Index

15

Concepts

All Affiliations

Skin Research Center
SH

About

Stephen H. Docter is an author at Skin Research Center specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

149

2

Biochemistry

4

4

128

3

Natural Sciences

2

2

89

4

Chemical Biology

1

1

68

5

Chemistry

1

1

21

Stephen H. Docter

×

5

Publications

149

Citations

5

H-Index

YearCitations

Structure−Activity Relationship Studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a Potent Inhibitor of Leukotriene A<sub>4</sub> (LTA<sub>4</sub>) Hydrolase

Thomas D. Penning, Nizal S. Chandrakumar, Barbara B. Chen,

Journal of Medicinal Chemistry

2000

68

Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: Impact upon Leukotriene B4- and 12(R)-HETE- mediated events

D. J. Fretland, C. P. Anglin, Meire Bremer,

Inflammation

1995

21

ChemInform Abstract: Synthesis and Biological Evaluation of the 1,5‐Diarylpyrazole Class of Cyclooxygenase‐2 Inhibitors: Identification of 4‐(5‐(4‐Methylphenyl)‐3‐ (trifluoromethyl)‐1H‐pyrazol‐1‐yl)benzenesulfonamide (SC‐58635, Celecoxib).

Thomas D. Penning, J. J. TALLAY, Stephen R. Bertenshaw,

ChemInform

1997

21

Synthesis of cinnamic acids and related isosteres as potent and selective αvβ3 receptor antagonists

Thomas D. Penning, Mark A. Russell, Barbara B. Chen,

Bioorganic & Medicinal Chemistry Letters

2004

20

Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity

Stevan W. Djurić, Stephen H. Docter, Stella S. Yu,

Bioorganic & Medicinal Chemistry Letters

1994

19

Page 1